|
|
|
|
| LEADER |
01815 am a22002773u 4500 |
| 001 |
68705 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Martin, Collin H.
|e author
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemical Engineering
|e contributor
|
| 100 |
1 |
0 |
|a Prather, Kristala L. J.
|e contributor
|
| 100 |
1 |
0 |
|a Martin, Collin H.
|e contributor
|
| 100 |
1 |
0 |
|a Nielsen, David R.
|e contributor
|
| 100 |
1 |
0 |
|a Solomon, Kevin
|e contributor
|
| 100 |
1 |
0 |
|a Prather, Kristala L. Jones
|e contributor
|
| 700 |
1 |
0 |
|a Nielsen, David R.
|e author
|
| 700 |
1 |
0 |
|a Solomon, Kevin
|e author
|
| 700 |
1 |
0 |
|a Prather, Kristala L. Jones
|e author
|
| 245 |
0 |
0 |
|a Synthetic Metabolism: Engineering Biology at the Protein and Pathway Scales
|
| 260 |
|
|
|b Elsevier B.V.,
|c 2012-01-30T16:22:10Z.
|
| 856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/68705
|
| 520 |
|
|
|a Biocatalysis has become a powerful tool for the synthesis of high-value compounds, particularly so in the case of highly functionalized and/or stereoactive products. Nature has supplied thousands of enzymes and assembled them into numerous metabolic pathways. Although these native pathways can be use to produce natural bioproducts, there are many valuable and useful compounds that have no known natural biochemical route. Consequently, there is a need for both unnatural metabolic pathways and novel enzymatic activities upon which these pathways can be built. Here, we review the theoretical and experimental strategies for engineering synthetic metabolic pathways at the protein and pathway scales, and highlight the challenges that this subfield of synthetic biology currently faces.
|
| 520 |
|
|
|a Synthetic Biology Engineering Research Center
|
| 520 |
|
|
|a National Science Foundation (Grant no. 0540879)
|
| 546 |
|
|
|a en_US
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Chemistry and Biology
|
